Clinton Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-43,577
Closed -$3.51M 749
2017
Q1
$3.51M Sell
43,577
-76,891
-64% -$6.01M 0.2% 144
2016
Q4
$8.58M Buy
+120,468
New +$9.46M 0.5% 45
2016
Q2
Sell
-182,181
Closed -$13.7M 988
2016
Q1
$13.7M Buy
182,181
+158,455
+668% +$11.9M 0.82% 8
2015
Q4
$1.82M Buy
+23,726
New +$1.79M 0.15% 220
2015
Q3
Sell
-7,899
Closed -$585K 782
2015
Q2
$585K Buy
+7,899
New +$604K 0.08% 349
2015
Q1
Sell
-35,871
Closed -$2.59M 559
2014
Q4
$2.59M Buy
+35,871
New +$2.49M 0.81% 7
2013
Q3
Sell
-19,458
Closed -$1M 383
2013
Q2
$1M Buy
+19,458
New +$962K 0.33% 36

Other funds holding MDT

Clinton Group's MDT Position: Q2 2017 in Review

Clinton Group sold out of Medtronic (MDT) in Q2 2017, closing a stake of 43,577 shares — an estimated $3.51M sold.

Clinton Group first reported a position in MDT in Q2 2013 and held it in 7 quarters. The position peaked at $13.7M in Q1 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Clinton Group reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Clinton Group sold 43,577 Medtronic shares in Q2 2017, an estimated $3.51M.
  • Clinton Group first reported a position in Medtronic in Q2 2013 and held it in 7 quarters.
  • Clinton Group's Medtronic position peaked at $13.7M in Q1 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.